ANAPTYSBIO INC (ANAB) Stock Income Statement
NASDAQ:ANAB - Nasdaq - US0327241065 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 111.87M | 91.28M | 17.16M | 10.29M | 63.18M | |||
| Operating Expenses | 212.16M | 206.23M | 174.23M | 125.44M | 119.99M | |||
| Research and Development | 167.98M | 163.84M | 132.28M | 88.80M | 98.50M | |||
| Selling, General, and Administrative Expenses | 44.18M | 42.39M | 41.95M | 36.64M | 21.49M | |||
| Operating Income | -100.29M | -114.95M | -157.07M | -115.15M | -56.81M | |||
| Interest Income/Expense | 19.62M | 19.79M | 18.87M | 7.55M | 430.00K | |||
| Other Income/Expense | -59.91M | -50.07M | -18.09M | -21.10M | -1.41M | |||
| Non Recurring Items | N/A | 0.00 | -7.34M | N/A | N/A | |||
| Income Before Taxes | -140.58M | -145.23M | -163.62M | -128.70M | -57.80M | |||
| Income Tax | 47.00K | 3.00K | -4.00K | 20.00K | 0.00 | |||
| Net Income | -140.62M | -145.23M | -163.62M | -128.72M | -57.80M | |||
| EBITDA | -99.70M | -114.34M | -156.42M | -114.47M | -56.19M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.84 | -5.12 | -6.08 | -4.57 | -2.11 | |||
| Non GAAP EPS | -4.85 | -5.21 | -6.08 | -4.57 | -2.05 | |||
| Statistics | ||||||||
| Profit Margin | -125.70% | -159.10% | -953.66% | -1250.92% | -91.48% | |||
| Operating Profit Margin | -89.64% | -125.93% | -915.50% | -1119.05% | -89.92% | |||
All data in USD